<?xml version="1.0" encoding="UTF-8"?>
<fig id="medicines-04-00062-f004" orientation="portrait" position="float" class="fig">
 <label class="label">Figure 4</label>
 <caption class="caption">
  <p class="p">Area Under Disease Progress Curve (AUDPC) for preventive and curative in vivo under positive control with water (0 = 0.0 µL mL
   <sup class="sup">−1</sup>) and negative control with methyl-thiophanate (6 = 2.0 mg mL
   <sup class="sup">−1</sup>), with five different concentrations (1 = 0.625 µL mL
   <sup class="sup">−1</sup>, 2 = 1.25 µL mL
   <sup class="sup">−1</sup>, 3 = 2.5 µL mL
   <sup class="sup">−1</sup>, 4 = 5 µL mL
   <sup class="sup">−1</sup>, and 5 = 7.5 µL mL
   <sup class="sup">−1</sup>) of the 
   <italic class="italic">Cymbopogon citratus</italic> essential oil.
  </p>
 </caption>
 <graphic xlink:href="medicines-04-00062-g004" class="graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
